Adverse event | AL tablets n = 133* (%) | AL suspension n = 134* (%) | p |
---|---|---|---|
Diarrhoea | 11 (8.3) | 10 (7.4) | 0.81 |
Vomiting during treatment** | 21 (2.6) | 12 (3.0) | 0.72 |
Rhinitis | 17(12.8) | 22 (16.4) | 0.40 |
Otitis Media | 1 (0.8) | 5 (3.7) | 0.21 |
Pneumonia | 3 (2.3) | 6 (4.5) | 0.50 |
Bacterial skin infections | 5 (3.8) | 5 (3.7) | 1.00 |
Fungal skin infections | 6 (4.5) | 5 (3.7) | 0.98 |
Eczematous rash | 1(0.8) | 5 (3.7) | 0.21 |
Contact dermatitis | 1 (0.8) | 1 (0.7) | 1.00 |
Conjunctivitis | 6 (4.5) | 7 (5.2) | 0.98 |